# Tom X Lee

> Tom X Lee is a seed investor at Galileo (New York) backing Health Care and Medical. See 18 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Galileo](https://shizune.co/investors/profile/galileo-health)
- Location: New York, United States
- Total investments: 18
- Last investment: Jan 2025
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: http://www.linkedin.com/in/tomxlee

Tom X Lee is a seed investor at Galileo in New York focused on Health Care and Medical. Tom X Lee is the CEO of Galileo. Took up BS, Biology at Yale University.

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $2.3M–$9.5M |
| Series A | $10M–$22M |
| Series B | $26M–$40M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 15 | 83% |
| Medical | 7 | 39% |
| Artificial Intelligence | 6 | 33% |
| Wellness | 3 | 17% |
| Health Diagnostics | 3 | 17% |

33 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 8 | 44% |
| Series A | 5 | 28% |
| Series B | 3 | 17% |
| Pre-Seed | 2 | 11% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Systole Health | Systole Health enables women to take immediate action to improve their health, prevent heart disease, and regain their well-being. Systole Health's mission is to transform women's heart health care by offering prompt, transformative assistance. | $2M | Pre-Seed | Jan 27, 2025 |  |
| Allara | Allara is a healthcare program that allows patients to access expert, specialty care through virtual appointments. Allara offers a medical provider and a registered dietitian for polycystic ovary syndrome. They provide holistic care, diagnostic testing, prescriptions, video appointments with a medical provider, dietary and lifestyle changes,nutrition counseling, and medication. | $26M | Series B | Jan 24, 2025 |  |
| Parakeet Health | Parakeet Health is a AI contact center agent for healthcare practices. | $3M | Seed | Oct 15, 2024 |  |
| Allara | Allara is a healthcare program that allows patients to access expert, specialty care through virtual appointments. Allara offers a medical provider and a registered dietitian for polycystic ovary syndrome. They provide holistic care, diagnostic testing, prescriptions, video appointments with a medical provider, dietary and lifestyle changes,nutrition counseling, and medication. | $10M | Series A | Oct 18, 2023 |  |
| Glass Health | Glass Health empowers clinicians with a platform for AI-assisted diagnosis and clinical decision-making | $5M | Seed | Sep 11, 2023 |  |
| Oula Health | Oula is redesigning maternity care from the ground up. Its modern maternity center combines the best of obstetrics and midwifery care to deliver a more evidence-based and personalized pregnancy experience. From its collaborative medical team, welcoming clinic, and remote care platform, we are setting a new standard for pregnancy that unifies modernmedicine and human intuition.The company was founded in 2019 and is headquartered in Brooklyn, New York. | $19.1M | Series A | Jan 12, 2023 |  |
| Nava | Nava is a new kind of benefits brokerage on a mission to bring high-quality, affordable healthcare to employers and their employees. It offers healthcare tools, year-round employee advocacy, and ongoing measurement to monitor and recommend healthcare plans, thus enabling clients to provide the required benefits to their employees while loweringoverall plan cost. | $40M | Series B | Jun 08, 2022 |  |
| Topography Health | Topography Health is creating new opportunities in clinical research. | $21.5M | Series A | Jan 19, 2022 |  |
| Commons Clinic | Commons Clinic is a multi-specialty clinic that provides healthcare treatment to patients. The company's clinic offers comprehensive specialty and surgical care programs for pain, orthopedics, women's health, and men's health, enabling patients to avail improved and efficient medical care.The company was founded in 2021 and isbased in Austin, Texas. | $6M | Seed | Sep 07, 2021 |  |
| Centaur Labs | Centaur offers a platform and services for expert data annotation. We provide unmatched accuracy and scale by harnessing the collective intelligence of a global network of tens of thousands of students and professionals who compete with each other to be the best data annotator. | $15M | Series A | Aug 17, 2021 |  |

10 of 18 investments shown.

## Co-investors
- [Gaingels](https://shizune.co/investors/profile/gaing) — VC Fund, 3 deals together
- [Google Ventures](https://shizune.co/investors/profile/google-ventures) — VC Fund, 3 deals together
- [Great Oaks Venture Capital](https://shizune.co/investors/profile/great-oaks-venture-capital) — VC Fund, 3 deals together
- [January Ventures](https://shizune.co/investors/profile/jane-vc) — VC Fund, 3 deals together
- [January Ventures](https://shizune.co/investors/profile/january-ventures) — VC Fund, 3 deals together
- [Amplo](https://shizune.co/investors/profile/amplo) — VC Fund, 2 deals together

## About Galileo

VC Fund · New York, United States

Galileo provides high-touch, data-driven, multi-specialty, longitudinal care to a diverse and complex patient population—over the phone, at home, and everywhere in between. Regional and national health plans, employers, and Fortune 500 companies all regard Galileo as the leading solution for improving population health. It aims to use that talentand scientific thinking to transform society by solving the most difficult healthcare problems while also bringing patients and providers closer together.

5 contacts available at Galileo.

| Name | Title | Profile |
| --- | --- | --- |
| John Caruso | Head of Insights | https://shizune.co/investors/profile/john-caruso-17c1 |
| Priya Kumar | Director of Health Plan Implementation & Engagement | https://shizune.co/investors/profile/priya-kumar |
| Ajay Haryani | Clinical Systems Director | https://shizune.co/investors/profile/ajay-haryani |
| Tom X Lee | CEO | https://shizune.co/investors/profile/tom-x-lee |
| Tom X Lee | CEO | https://shizune.co/investors/profile/thomas-lee-0b4f |

## Similar investors

### Similar industry
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## Featured in investor lists
- [Health Care Angel Investors in United States](https://shizune.co/investors/health-care-angel-investors-united-states)
- [Health Care Angel Investors](https://shizune.co/investors/health-care-angel-investors)
- [Medical Angel Investors](https://shizune.co/investors/medical-angel-investors)
- [Medical Angel Investors in United States](https://shizune.co/investors/medical-angel-investors-united-states)
- [Wellness Angel Investors in United States](https://shizune.co/investors/wellness-angel-investors-united-states)
- [Life Science Angel Investors](https://shizune.co/investors/life-science-angel-investors)

## FAQ

### What does Tom X Lee invest in?

Tom X Lee invests primarily in Health Care, Medical and Artificial Intelligence startups, most often at Seed and Series A stage. Most of the 18 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Tom X Lee's check size?

Tom X Lee typically joins rounds of $2.3M–$9.5M at Seed, $10M–$22M at Series A and $26M–$40M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Tom X Lee participates in.

### When did Tom X Lee last invest?

The most recent investment recorded for Tom X Lee closed in Jan 2025. Shizune tracks 18 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co